Related references
Note: Only part of the references are listed.SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation-Specific Fusion Transcript in Prostate Cancer
David S. Rickman et al.
CANCER RESEARCH (2009)
Canonical WNT signalling determines lineage specificity in Wilms tumour
R. Fukuzawa et al.
ONCOGENE (2009)
Identification of a Putative Network of Actin-Associated Cytoskeletal Proteins in Glomerular Podocytes Defined by Co-Purified mRNAs
Behnam Nabet et al.
PLOS ONE (2009)
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Caroline Vance et al.
SCIENCE (2009)
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
T. J. Kwiatkowski et al.
SCIENCE (2009)
Huntington's disease: from pathology and genetics to potential therapies
Sara Imarisio et al.
BIOCHEMICAL JOURNAL (2008)
Mechanisms of neurodegeneration in Huntington's disease
Joana M. Gil et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Assessing RNA quality in postmortem human brain tissue
Ia Chevyreva et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2008)
Huntingtin Modulates Transcription, Occupies Gene Promoters In Vivo, and Binds Directly to DNA in a Polyglutamine-Dependent Manner
Caroline L. Benn et al.
JOURNAL OF NEUROSCIENCE (2008)
Postmortem delay has minimal effect on brain RNA integrity
John F. Ervin et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
beadarray:: R classes and methods for Illumina bead-based data
Mark J. Dunning et al.
BIOINFORMATICS (2007)
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage
Alexandre Kuhn et al.
HUMAN MOLECULAR GENETICS (2007)
Plastic abnormalities in experimental Huntington's disease
Massimiliano Di Filippo et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Interpretation of multiple probe sets mapping to the same gene in Affymetrix GeneChips
Maria A. Stalteri et al.
BMC BIOINFORMATICS (2007)
Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function
Arturo J. Cardounel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Striatal specificity of gene expression dysregulation in Huntington's disease
Elizabeth A. Thomas
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain
A. A. Morrison et al.
BIOCHEMISTRY AND CELL BIOLOGY (2006)
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin
Rona K. Graham et al.
CELL (2006)
Huntingtin inclusions do not down-regulate specific genes in the R6/2 Huntington's disease mouse
G. Sadri-Vakili et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations
Susan F. Crocker et al.
BRAIN RESEARCH (2006)
Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease
AS Chen-Plotkin et al.
NEUROBIOLOGY OF DISEASE (2006)
Regional and cellular gene expression changes in human Huntington's disease brain
A Hodges et al.
HUMAN MOLECULAR GENETICS (2006)
Brain-specific regulator of G-protein signaling 9-2 selectively interacts with α-actinin-2 to regulate calcium-dependent inactivation of NMDA receptors
M Bouhamdan et al.
JOURNAL OF NEUROSCIENCE (2006)
Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease
PA Desplats et al.
JOURNAL OF NEUROCHEMISTRY (2006)
In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets
WG Zhai et al.
CELL (2005)
Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease
JM Van Raamsdonk et al.
JOURNAL OF NEUROSCIENCE (2005)
Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1
B Zucker et al.
HUMAN MOLECULAR GENETICS (2005)
Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms
M Barnes et al.
NUCLEIC ACIDS RESEARCH (2005)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
Genomic imprinting of PPP1R9A encoding neurabin I in skeletal muscle and extra-embryonic tissues
K Nakabayashi et al.
JOURNAL OF MEDICAL GENETICS (2004)
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease
EJ Slow et al.
HUMAN MOLECULAR GENETICS (2003)
Transcriptional abnormalities in Huntington disease
KL Sugars et al.
TRENDS IN GENETICS (2003)
Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation
R Luthi-Carter et al.
NEUROBIOLOGY OF DISEASE (2003)
Insoluble TATA-binding protein accumulation in Huntington's disease cortex
WMC van Roon-Mom et al.
MOLECULAR BRAIN RESEARCH (2002)
cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO
GP Ahern et al.
TRENDS IN NEUROSCIENCES (2002)
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2002)
Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2002)
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease
EYW Chan et al.
HUMAN MOLECULAR GENETICS (2002)
Targeting protein phosphatase 1 (PP1) to the actin cytoskeleton: the neurabin I/PP1 complex regulates cell morphology
CJ Oliver et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease
AW Dunah et al.
SCIENCE (2002)
Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington's disease transgenic mice
AW Deckel et al.
BRAIN RESEARCH (2002)
Interaction of Huntington disease protein with transcriptional activator Sp1
SH Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase
J Murray-Rust et al.
NATURE STRUCTURAL BIOLOGY (2001)
Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
FC Nucifora et al.
SCIENCE (2001)
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
JS Steffan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2000)
Expanded polyglutamine stretches interact with TAF(II)130, interfering with CREB-dependent transcription
T Shimohata et al.
NATURE GENETICS (2000)
CREB-binding protein sequestration by expanded polyglutamine
A McCampbell et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
